339 / 1498
Overview of talk
1.
Review clinical data on management of early stage HL
–
Should combined modality treatment still be the
standard approach ?
2.
Recent progress in using FDG PET to guide therapy and
delivery of RT in HL
-
Are we ready to make treatments decisions based on
FDG-PET to potentially omit RT ?